Drug Type Small molecule drug |
Synonyms ABSK 141, ABSK141 |
Target |
Action inhibitors |
Mechanism KRAS G12D inhibitors(GTPase KRas G12D inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | IND Approval | China | 19 Dec 2025 | |
| KRAS G12D mutation Solid Tumors | IND Approval | United States | 01 Dec 2025 | |
| Neoplasms | Discovery | China | - |





